The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Strategies to Overcome Antimicrobial Resistance (AMR) Making Use of Non-Essential Target Inhibitors: A Review
Open accessAbstract
Antibiotics have always been considered as one of the most relevant discoveries of the twentieth century. Unfortunately, the dawn of the antibiotic era has sadly corresponded to the rise of the phenomenon of antimicrobial resistance (AMR), which is a natural process whereby microbes evolve in such a way to withstand the action of drugs. In this context, the identification of new potential antimicrobial targets and/or the identification of new chemical entities as antimicrobial drugs are in great demand. To date, among the many possible approaches used to deal with antibiotic resistance is the use of antibiotic adjuvants that hit bacterial non-essential targets. In this review, the author focuses on the discovery of antibiotic adjuvants and on new tools to study and reduce the prevalence of resistant bacterial infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biofilms: an emergent form of bacterial life
Flemming, H.-C., Wingender, J., Szewzyk, U., Steinberg, P., Rice, S. A., & Kjelleberg, S. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.94 · Cited by 5,979
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
The antibiotic resistance crisis: part 1: causes and threats.
Ventola, C. L. (2015) · PubMed · Cited by 4,516
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316
Molecular mechanisms of antibiotic resistance
Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. V. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3380 · Cited by 4,092
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., & Collins, J. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.049 · Cited by 2,982
Cassini, A., Högberg, L. D., Plachouras, D., Quattrocchi, A., Hoxha, A., Simonsen, G. S., Colomb-Cotinat, M., Kretzschmar, M. E., Devleesschauwer, B., Cecchini, M., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30605-4 · Cited by 2,945
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,618
Antibiotic resistance: a rundown of a global crisis
Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., Muzammil, S., Rasool, M. H., Nisar, M. A., Alvi, R. F., Aslam, M. A., Qamar, M. U., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s173867 · Cited by 2,552
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Bacterial Quorum Sensing: Its Role in Virulence and Possibilities for Its Control
Rutherford, S. T., & Bassler, B. L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012427 · Cited by 2,129
Antibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 1,955
Targeting microbial biofilms: current and prospective therapeutic strategies
Koo, H., Allan, R. N., Howlin, R. P., Stoodley, P., & Hall-Stoodley, L. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.99 · Cited by 1,800
Outer membrane permeability and antibiotic resistance
Delcour, A. H. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.11.005 · Cited by 1,762
A brief history of the antibiotic era: lessons learned and challenges for the future
Aminov, R. I. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00134 · Cited by 1,628
Molecular mechanisms that confer antibacterial drug resistance
Walsh, C. (2000) · Nature · doi:10.1038/35021219 · Cited by 1,578
Efflux-mediated heavy metal resistance in prokaryotes
Nies, D. H. (2003) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(03)00048-2 · Cited by 1,557
Targeting virulence: a new paradigm for antimicrobial therapy
Clatworthy, A. E., Pierson, E., & Hung, D. T. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.24 · Cited by 1,406
Anti-virulence strategies to combat bacteria-mediated disease
Rasko, D. A., & Sperandio, V. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3013 · Cited by 1,373
Lebeaux, D., Ghigo, J.-M., & Beloin, C. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00013-14 · Cited by 1,318
Tackling antibiotic resistance
Bush, K., Courvalin, P., Dantas, G., Davies, J., Eisenstein, B., Huovinen, P., Jacoby, G. A., Kishony, R., Kreiswirth, B. N., Kutter, E., et al. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2693 · Cited by 1,062
Origins and evolution of antibiotic resistance.
DAVIES, J. E. (1996) · PubMed · Cited by 1,033
Action and resistance mechanisms of antibiotics: A guide for clinicians
Kapoor, G., Saigal, S., & Elongavan, A. (2017) · Journal of Anaesthesiology Clinical Pharmacology · doi:10.4103/joacp.joacp_349_15 · Cited by 1,022
Bassler, B. L., & Losick, R. (2006) · Cell · doi:10.1016/j.cell.2006.04.001 · Cited by 983
Efflux-Mediated Drug Resistance in Bacteria: An Update
Li, X.-Z., & Nikaido, H. (2009) · Drugs · doi:10.2165/11317030-000000000-00000 · Cited by 966
Hurdle, J. G., O'Neill, A. J., Chopra, I., & Lee, R. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2474 · Cited by 871
The importance of efflux pumps in bacterial antibiotic resistance
Webber, M. A. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg050 · Cited by 853
de la Fuente-Núñez, C., Reffuveille, F., Fernández, L., & Hancock, R. E. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.013 · Cited by 801
Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
Dickey, S. W., Cheung, G. Y. C., & Otto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.23 · Cited by 799
Mechanisms of Solvent Tolerance in Gram-Negative Bacteria
Ramos, J. L., Duque, E., Gallegos, M.-T., Godoy, P., Ramos-González, M. I., Rojas, A., Terán, W., & Segura, A. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.161038 · Cited by 791
The biology and future prospects of antivirulence therapies
Cegelski, L., Marshall, G. R., Eldridge, G. R., & Hultgren, S. J. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1818 · Cited by 788
The future challenges facing the development of new antimicrobial drugs
Coates, A., Hu, Y., Bax, R., & Page, C. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd940 · Cited by 704
Galloway, W. R. J. D., Hodgkinson, J. T., Bowden, S. D., Welch, M., & Spring, D. R. (2011) · Chemical Reviews · doi:10.1021/cr100109t · Cited by 665
ESKAPEing the labyrinth of antibacterial discovery
Tommasi, R., Brown, D. G., Walkup, G. K., Manchester, J. I., & Miller, A. A. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4572 · Cited by 608
McMurry, L., Petrucci, R. E., & Levy, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3974 · Cited by 604
Antibiotic Adjuvants: Rescuing Antibiotics from Resistance
Wright, G. D. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.06.009 · Cited by 604
Antimicrobial peptides: General overview and clinical implications in human health and disease
Guaní-Guerra, E., Santos-Mendoza, T., Lugo-Reyes, S. O., & Terán, L. M. (2010) · Clinical Immunology · doi:10.1016/j.clim.2009.12.004 · Cited by 549
Quorum sensing in bacterial virulence
Antunes, L. C. M., Ferreira, R. B. R., Buckner, M. M. C., & Finlay, B. B. (2010) · Microbiology · doi:10.1099/mic.0.038794-0 · Cited by 537
Targeting virulence: can we make evolution-proof drugs?
Allen, R. C., Popat, R., Diggle, S. P., & Brown, S. P. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3232 · Cited by 532
Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism
Adams, K. N., Takaki, K., Connolly, L. E., Wiedenhoft, H., Winglee, K., Humbert, O., Edelstein, P. H., Cosma, C. L., & Ramakrishnan, L. (2011) · Cell · doi:10.1016/j.cell.2011.02.022 · Cited by 530
Broad-Spectrum Anti-biofilm Peptide That Targets a Cellular Stress Response
de la Fuente-Núñez, C., Reffuveille, F., Haney, E. F., Straus, S. K., & Hancock, R. E. W. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004152 · Cited by 521
Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms
Van Acker, H., Van Dijck, P., & Coenye, T. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.02.001 · Cited by 520
Multidrug resistance mechanisms: drug efflux across two membranes
Zgurskaya, H. I., & Nikaido, H. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01926.x · Cited by 466
Hecker, S. J., Reddy, K. R., Totrov, M., Hirst, G. C., Lomovskaya, O., Griffith, D. C., King, P., Tsivkovski, R., Sun, D., Sabet, M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00127 · Cited by 422
Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter
Neyfakh, A. A., Borsch, C. M., & Kaatz, G. W. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.1.128 · Cited by 361
Responses of Pseudomonas aeruginosa to antimicrobials
Morita, Y., Tomida, J., & Kawamura, Y. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00422 · Cited by 344
Robust Salmonella metabolism limits possibilities for new antimicrobials
Becker, D., Selbach, M., Rollenhagen, C., Ballmaier, M., Meyer, T. F., Mann, M., & Bumann, D. (2006) · Nature · doi:10.1038/nature04616 · Cited by 335
Phylogeny of multidrug transporters
Saier, Jr., & Paulsen, I. T. (2001) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0246 · Cited by 333
The Future of Antibiotics and Resistance: A Tribute to a Career of Leadership by John Bartlett
Spellberg, B., & Gilbert, D. N. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu392 · Cited by 324
β-Lactamases: A Focus on Current Challenges
Bonomo, R. A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025239 · Cited by 318
Resistance to polymyxins: Mechanisms, frequency and treatment options
Falagas, M. E., Rafailidis, P. I., & Matthaiou, D. K. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.05.002 · Cited by 298
A Broad-Spectrum Antibiofilm Peptide Enhances Antibiotic Action against Bacterial Biofilms
Reffuveille, F., de la Fuente-Núñez, C., Mansour, S., & Hancock, R. E. W. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03163-14 · Cited by 293
Starkey, M., Lepine, F., Maura, D., Bandyopadhaya, A., Lesic, B., He, J., Kitao, T., Righi, V., Milot, S., Tzika, A., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004321 · Cited by 273
Ilangovan, A., Fletcher, M., Rampioni, G., Pustelny, C., Rumbaugh, K., Heeb, S., Cámara, M., Truman, A., Chhabra, S. R., Emsley, J., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003508 · Cited by 264
Novel Strategies for the Treatment of Pseudomonas aeruginosa Infections
Wagner, S., Sommer, R., Hinsberger, S., Lu, C., Hartmann, R. W., Empting, M., & Titz, A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01698 · Cited by 258
Antibiotic adjuvants – A strategy to unlock bacterial resistance to antibiotics
González-Bello, C. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.08.027 · Cited by 254
Strategies for bypassing the membrane barrier in multidrug resistant Gram‐negative bacteria
Bolla, J.-M., Alibert-Franco, S., Handzlik, J., Chevalier, J., Mahamoud, A., Boyer, G., Kieć-Kononowicz, K., & Pagès, J.-M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.054 · Cited by 250
Inhibitors of efflux pumps in Gram-negative bacteria
Pagès, J.-M., Masi, M., & Barbe, J. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.06.006 · Cited by 238
Goff, D. A., Kullar, R., Goldstein, E. J. C., Gilchrist, M., Nathwani, D., Cheng, A. C., Cairns, K. A., Escandón-Vargas, K., Villegas, M. V., Brink, A., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30386-3 · Cited by 233
Geske, G. D., O’Neill, J. C., & Blackwell, H. E. (2008) · Chemical Society Reviews · doi:10.1039/b703021p · Cited by 232
Bohnert, J. A., & Kern, W. V. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.849-852.2005 · Cited by 226
Lomovskaya, O., Lee, A., Hoshino, K., Ishida, H., Mistry, A., Warren, M. S., Boyer, E., Chamberland, S., & Lee, V. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1340 · Cited by 220
Novel approaches to developing new antibiotics for bacterial infections
Coates, A. R. M., & Hu, Y. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707432 · Cited by 218
Ceragenins: Cholic Acid-Based Mimics of Antimicrobial Peptides
Lai, X.-Z., Feng, Y., Pollard, J., Chin, J. N., Rybak, M. J., Bucki, R., Epand, R. F., Epand, R. M., & Savage, P. B. (2008) · Accounts of Chemical Research · doi:10.1021/ar700270t · Cited by 214
Beta-lactamase inhibitors from laboratory to clinic
Bush, K. (1988) · Clinical Microbiology Reviews · doi:10.1128/cmr.1.1.109 · Cited by 212
Survival of the fittest: how Brucella strains adapt to their intracellular niche in the host
Roop, R. M., Gaines, J. M., Anderson, E. S., Caswell, C. C., & Martin, D. W. (2009) · Medical Microbiology and Immunology · doi:10.1007/s00430-009-0123-8 · Cited by 210
Revisiting the host as a growth medium
Brown, S. A., Palmer, K. L., & Whiteley, M. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1955 · Cited by 208
Fighting bacterial infections—Future treatment options
Fernebro, J. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.02.001 · Cited by 199
Regulation of l-Cysteine Biosynthesis in Salmonella typhimurium
Kredich, N. M. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62154-4 · Cited by 192
Membrane Permeability and Regulation of Drug “Influx and Efflux” in Enterobacterial Pathogens
Davin-Regli, A., Bolla, J.-M., James, C., Lavigne, J.-P., Chevalier, J., Garnotel, E., Molitor, A., & Pages, J.-M. (2008) · Current Drug Targets · doi:10.2174/138945008785747824 · Cited by 188
Emerging Issues in Gram-Negative Bacterial Resistance
Vasoo, S., Barreto, J. N., & Tosh, P. K. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.12.002 · Cited by 182
Mahamoud, A., Chevalier, J., Davin-Regli, A., Barbe, J., & Pages, J.-M. (2006) · Current Drug Targets · doi:10.2174/138945006777709557 · Cited by 177
Inhibitors of Multidrug Resistant Efflux Systems in Bacteria
Zechini, B., & Versace, I. (2009) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489109787236256 · Cited by 172
Quorum Sensing Inhibition Selects for Virulence and Cooperation in Pseudomonas aeruginosa
Köhler, T., Perron, G. G., Buckling, A., & van Delden, C. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000883 · Cited by 171
Modulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily
Kumar, S., Mukherjee, M. M., & Varela, M. F. (2013) · International Journal of Bacteriology · doi:10.1155/2013/204141 · Cited by 166
Adams, K. N., Szumowski, J. D., & Ramakrishnan, L. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu095 · Cited by 164
Pradel, E., & Pagès, J.-M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2640-2643.2002 · Cited by 163
The Antibiotic Resistance Crisis
Jha, K. K., Saini, S., Raj, A., Shreyasi, S., & Bishnoi, H. (2023) · Asian Journal of Pharmaceutical Research and Development · doi:10.22270/ajprd.v11i5.1321 · Cited by 159
Microbial Efflux Pump Inhibition: Tactics and Strategies
Tegos, G. P., Haynes, M. K., Strouse, J. J., Khan, M. M. T., Bologa, C., Oprea, T. I., & Sklar, L. A. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795703726 · Cited by 158
Drug Targets in Mycobacterial Sulfur Metabolism
Bhave, D. P., Muse, W. B., & Carroll, K. S. (2007) · Infectious Disorders - Drug Targets · doi:10.2174/187152607781001772 · Cited by 152
Lapuebla, A., Abdallah, M., Olafisoye, O., Cortes, C. D., Urban, C. M., Quale, J. M., & Landman, D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00843-15 · Cited by 147
Chemical Strategies To Target Bacterial Virulence
Garland, M., Loscher, S., & Bogyo, M. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00676 · Cited by 147
New developments in tetracycline antibiotics: Glycylcyclines and tetracycline efflux pump inhibitors
Chopra, I. (2002) · Drug Resistance Updates · doi:10.1016/s1368-7646(02)00051-1 · Cited by 143
Biedenbach, D. J., Kazmierczak, K. M., Bouchillon, S. K., Sahm, D. F., & Bradford, P. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00206-15 · Cited by 141
Bryson, H. M., & Brogden, R. N. (1994) · Drugs · doi:10.2165/00003495-199447030-00008 · Cited by 132
Bailey, A. M., Paulsen, I. T., & Piddock, L. J. V. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00661-08 · Cited by 132
Li, H., Estabrook, M. A., Jacoby, G. A., Nichols, W. W., TESTA, R. T., & Bush, K. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04191-14 · Cited by 130
Schumacher, A., Steinke, P., Bohnert, J. A., Akova, M., Jonas, D., & Kern, W. V. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki446 · Cited by 126
Li, C., Peters, A. S., Meredith, E. L., et al. (1998) · Journal of the American Chemical Society · doi:10.1021/ja973881r · Cited by 125
Polymyxins and their novel derivatives
Vaara, M. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.09.002 · Cited by 124
Li, C., Budge, L. P., Driscoll, C. D., Willardson, B. M., Allman, G. W., & Savage, P. B. (1999) · Journal of the American Chemical Society · doi:10.1021/ja982938m · Cited by 122
Cysteine biosynthesis, oxidative stress and antibiotic resistance in Salmonella typhimurium
Turnbull, A. L., & Surette, M. G. (2010) · Research in Microbiology · doi:10.1016/j.resmic.2010.06.004 · Cited by 120
Campoli-Richards, D. M., & Brogden, R. N. (1987) · Drugs · doi:10.2165/00003495-198733060-00003 · Cited by 119
In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin
Wise, R. A., Andrews, J. M., & Bedford, K. A. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.13.3.389 · Cited by 116
The CymR Regulator in Complex with the Enzyme CysK Controls Cysteine Metabolism in Bacillus subtilis
Tanous, C., Soutourina, O. A., Raynal, B. D. E., Hullo, M.-F., Mervelet, P., Gilles, A., Noirot, P. H., Danchin, A., England, P., & Martin‐Verstraete, I. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805951200 · Cited by 105
Sulfate Metabolism in Mycobacteria
Schelle, M. W., & Bertozzi, C. R. (2006) · ChemBioChem · doi:10.1002/cbic.200600224 · Cited by 104
Efflux systems in bacterial pathogens: An opportunity for therapeutic intervention? An industry view
Lynch, A. S. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.021 · Cited by 103
Polyamines Increase Antibiotic Susceptibility in Pseudomonas aeruginosa
Kwon, D. H., & Lu, C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1623-1627.2006 · Cited by 102
Extended-Spectrum β-Lactamases (ESBLs): Characterization, Epidemiology and Detection
Shah, A. A., Hasan, F., Ahmed, S., & Hameed, A. (2004) · Critical Reviews in Microbiology · doi:10.1080/10408410490266429 · Cited by 102
Diner, E. J., Beck, C. M., Webb, J. S., Low, D. A., & Hayes, C. S. (2012) · Genes & Development · doi:10.1101/gad.182345.111 · Cited by 93
Confronting the challenges of discovery of novel antibacterial agents
Singh, S. B. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.06.053 · Cited by 92
Farrell, D. J., Morrissey, I., Bakker, S., Morris, L., Buckridge, S., & Felmingham, D. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.2.764-768.2004 · Cited by 90
Pearson, M. M., Yep, A., Smith, S. N., & Mobley, H. L. T. (2011) · Infection and Immunity · doi:10.1128/iai.05152-11 · Cited by 86
Turnbull, A. L., & Surette, M. G. (2008) · Microbiology · doi:10.1099/mic.0.2008/020347-0 · Cited by 85
Nikaido, H., & Zgurskaya, H. I. (1999) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-199912000-00001 · Cited by 80
Inactivation of pyridoxal phosphate dependent enzymes by mono- and polyhaloalanines
Silverman, R. B., & Abeles, R. H. (1976) · Biochemistry · doi:10.1021/bi00666a028 · Cited by 78
Chan, Y. Y., Ong, Y. M., & Chua, K. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01033-06 · Cited by 74
Structural Insights into Outer Membrane Permeability of Acinetobacter baumannii
Zahn, M., Bhamidimarri, S. P., Baslé, A., Winterhalter, M., & van den Berg, B. (2016) · Structure · doi:10.1016/j.str.2015.12.009 · Cited by 74
Livermore, D. M., Mushtaq, S., Warner, M., & Woodford, N. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv239 · Cited by 74
Brunner, K., Maric, S., Reshma, R. S., Almqvist, H., Seashore-Ludlow, B. A., Gustavsson, A., Poyraz, O., Yogeeswari, P., Lundbäck, T., Vallin, M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00674 · Cited by 73
Andrade, J. C., Morais‐Braga, M. F. B., Guedes, G. M. D. M., Tintino, S. R., de Freitas, M. A., Quintans‐Júnior, L. J., de Menezes, I. R. A., & Coutinho, H. D. M. (2015) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2015.09.004 · Cited by 64
Zhanel, G. G., Hoban, D. J., Schurek, K. N., & Karlowsky, J. A. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.08.003 · Cited by 59
Kanagaratnam, R., Sheikh, R., Alharbi, F., & Kwon, D. H. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.10.010 · Cited by 57
Mistry, S., Roy, S., Maitra, N. J., Kundu, B., Chanda, A., Datta, S., & Joy, M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.08.014 · Cited by 54
The multifaceted pyridoxal 5′-phosphate-dependent O-acetylserine sulfhydrylase
Mozzarelli, A., Bettati, S., Campanini, B., Salsi, E., Raboni, S., Singh, R., Spyrakis, F., Kumar, V. P., & Cook, P. F. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.04.011 · Cited by 50
Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy
Pieroni, M., Machado, D., Azzali, E., Costa, S. S., Couto, I., Costantino, G., & Viveiros, M. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00428 · Cited by 44
Amori, L., Katkēviča, S., Bruno, A., Campanini, B., Felici, P., Mozzarelli, A., & Costantino, G. (2012) · MedChemComm · doi:10.1039/c2md20100c · Cited by 44
Li, Y., Sun, X., Feng, J., & Mo, H. (2015) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2015.07.009 · Cited by 42
Alexeev, D. G., Baxter, R. L., Campopiano, D. J., Kerbarh, O., Sawyer, L., Tomczyk, N., Watt, R. M., & Webster, S. P. (2006) · Organic & Biomolecular Chemistry · doi:10.1039/b517922j · Cited by 36
Human kynurenine aminotransferase II – reactivity with substrates and inhibitors
Passera, E., Campanini, B., Rossi, F., Casazza, V., Rizzi, M., Pellicciari, R., & Mozzarelli, A. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08106.x · Cited by 34
Synthetic Membrane-Targeted Antibiotics
Vooturi, S. K., & Firestine, S. M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791331059 · Cited by 31
Tohidpour, A., Peerayeh, S. N., Mehrabadi, J. F., & Yazdi, H. R. (2009) · Current Microbiology · doi:10.1007/s00284-009-9444-5 · Cited by 30
Fluorinated Mechanism-Based Inhibitors: Common Themes and Recent Developments
Tysoe, C., & Withers, S. G. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666140202204602 · Cited by 30
Ceragenins – a new weapon to fight multidrug resistant bacterial infections
Surel, U., Niemirowicz, K., Marzec, M., Savage, P. B., & Bucki, R. (2014) · Medical Studies · doi:10.5114/ms.2014.45428 · Cited by 26
Pseudomonas cepacia susceptibility to sulbactam
Jacoby, G. A., & Sutton, L. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.4.583 · Cited by 23
Flamm, R. K., Farrell, D. J., Sader, H. S., & Jones, R. N. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.01.003 · Cited by 21
Inhibition ofO-acetylserine sulfhydrylase by fluoroalanine derivatives
Franko, N., Grammatoglou, K., Campanini, B., Costantino, G., Jirgensons, A., & Mozzarelli, A. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1504040 · Cited by 21
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases
Annunziato, G., Giovati, L., Angeli, A., Pavone, M., Prete, S. D., Pieroni, M., Capasso, C., Bruno, A., Conti, S., Magliani, W., et al. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1516652 · Cited by 19
Self-citationβ-Lactamases, β-lactamase inhibitors, and skin and skin-structure infections
Neu, H. C. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(90)70121-w · Cited by 11
Phillips, R. S., & Dua, R. K. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90602-s · Cited by 6
Cited by
Towards the sustainable discovery and development of new antibiotics
Miethke, M., Pieroni, M., Weber, T., Brönstrup, M., Hammann, P., Halby, L., Arimondo, P. B., Glaser, P., Aigle, B., Bode, H. B., et al. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00313-1 · Cited by 1,151
Naik, G. A. R. R., Roy, A. A., Mutalik, S., & Dhas, N. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134977 · Cited by 47
Metadata
- Authors
- Annunziato, G.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-11-21
- Volume
- 20
- Issue
- 23
- Pages
- 5844
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2991107860
- Cited by
- 256
- References
- 132
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.